ATE151640T1 - Verwendung von protease-inhibitoren als antiexudative, antiphlogistische und antimikrobielle mittel - Google Patents

Verwendung von protease-inhibitoren als antiexudative, antiphlogistische und antimikrobielle mittel

Info

Publication number
ATE151640T1
ATE151640T1 AT90310516T AT90310516T ATE151640T1 AT E151640 T1 ATE151640 T1 AT E151640T1 AT 90310516 T AT90310516 T AT 90310516T AT 90310516 T AT90310516 T AT 90310516T AT E151640 T1 ATE151640 T1 AT E151640T1
Authority
AT
Austria
Prior art keywords
antiphlogistic
antiexudative
protease inhibitors
antimicrobial agents
per
Prior art date
Application number
AT90310516T
Other languages
English (en)
Inventor
Jitka Cejkova
Jiri Vacik
Zdenek Lojda
Original Assignee
Ceskoslovenska Akademie Ved
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceskoslovenska Akademie Ved filed Critical Ceskoslovenska Akademie Ved
Application granted granted Critical
Publication of ATE151640T1 publication Critical patent/ATE151640T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Centrifugal Separators (AREA)
  • Saccharide Compounds (AREA)
AT90310516T 1989-09-29 1990-09-26 Verwendung von protease-inhibitoren als antiexudative, antiphlogistische und antimikrobielle mittel ATE151640T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS895552A CS275231B2 (en) 1989-09-29 1989-09-29 Medicine bottle

Publications (1)

Publication Number Publication Date
ATE151640T1 true ATE151640T1 (de) 1997-05-15

Family

ID=5400638

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90310516T ATE151640T1 (de) 1989-09-29 1990-09-26 Verwendung von protease-inhibitoren als antiexudative, antiphlogistische und antimikrobielle mittel

Country Status (7)

Country Link
US (1) US5244673A (de)
EP (1) EP0420600B1 (de)
AT (1) ATE151640T1 (de)
AU (1) AU6317090A (de)
CA (1) CA2026166A1 (de)
CS (1) CS275231B2 (de)
DE (1) DE69030476T2 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций
ES2179038T3 (es) * 1991-09-13 2003-01-16 Pentapharm Ag Fraccion porteinica para el tratamiento cosmetico y dermatologico de la piel.
FI920206A0 (fi) * 1992-01-17 1992-01-17 Pekka Untamo Heino Medicinsk anvaendning, medicinskt foerfarande och preparat.
GB2271507A (en) * 1992-09-04 1994-04-20 Summit Technology Ireland Bv Compositions containing plasmin activity inhibitors
US5783532A (en) * 1993-06-17 1998-07-21 Allergan Enzyme compositions and methods for contact lens cleaning
IL109705A (en) * 1993-06-17 1998-07-15 Allergan Inc Enzyme compositions and methods for contact lens cleaning
WO1995009905A1 (en) * 1993-10-06 1995-04-13 Allergan, Inc. Compositions and methods for inhibiting and reducing lysozyme deposition on hydrophilic contact lenses
US5688781A (en) * 1994-08-19 1997-11-18 Bristol-Myers Squibb Company Method for treating vascular leak syndrome
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
EP0995435B1 (de) * 1997-05-14 2007-04-25 Senju Pharmaceutical Co., Ltd. Wässrige suspensionspräparationen mit exzellenter redispersibilität
CA2343038A1 (en) * 1998-09-28 2000-04-06 Maria Emanuel Ryan A novel inhibitor of cataract formation
US6914057B1 (en) 1998-09-28 2005-07-05 The Research Foundation Of State University Of New York Inhibitor of cataract formation
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
KR100450864B1 (ko) * 2001-11-23 2004-10-01 한국과학기술연구원 Ｒｎａ 표적 분자에 대해 특이성이 향상된네오마이신-클로람페니콜 헤테로 이합체 및 그의 제조방법
DE10227938B4 (de) * 2002-06-21 2006-07-20 Heraeus Kulzer Gmbh Pharmazeutische Zubereitung, Verfahren zu ihrer Herstellung sowie deren Verwendung
AU2003286258B2 (en) * 2002-11-20 2006-12-21 Arriva-Prometic Inc. Composition and method for treating inflammatory diseases using protease inhibitors
WO2005102303A2 (en) * 2004-04-21 2005-11-03 Advanced Ocular Systems Limited Antiprostaglandins for the treatment of ocular pathologies
US20070248646A1 (en) * 2006-02-16 2007-10-25 Ali Hafezi-Moghadam Use of azurocidin inhibitors in prevention and treatment of ocular vascular leakage
TW200812645A (en) * 2006-06-15 2008-03-16 Serenex Inc Tetracycline package formulations
FI20105572A0 (fi) 2010-05-24 2010-05-24 Prevab R Lcc Muokattu beeta-laktamaasi ja siihen liittyvät menetelmät ja käytöt
US9290754B2 (en) 2014-04-17 2016-03-22 Synthetic Biologics Inc. Beta-lactamases with improved properties for therapy
EP3186379B1 (de) 2014-08-28 2020-04-08 Synthetic Biologics, Inc. Auf e. coli basierende herstellung von beta-lactamase
CN107148473B (zh) 2014-10-08 2021-08-06 合成生物制品有限公司 β-内酰胺酶制剂及其用途
EP3236993B1 (de) 2014-12-23 2023-09-13 Theriva Biologics, Inc. Verfahren und zusammensetzungen zur hemmung oder verhinderung von unerwünschten wirkungen oraler antibiotika
AU2016222936B2 (en) 2015-02-23 2022-01-06 Theriva Biologics, Inc. Carbapenemases for use with antibiotics for the protection of the intestinal microbiome
KR20170122776A (ko) 2015-03-06 2017-11-06 신세틱 바이오로직스, 인코퍼레이티드 마이크로바이옴 보호를 위한 안전하고 유효한 베타-락타마제 투약
WO2017146603A1 (en) * 2016-02-24 2017-08-31 Arcasiu Nicolae Pharmaceutical composition for the treatment of burns, use, and method of treatment
WO2018075810A1 (en) * 2016-10-18 2018-04-26 Somahultion, Llc Dermatological compositions for providing nutrients to skin and methods thereof
US10328154B2 (en) * 2017-10-27 2019-06-25 BUFFERAD Illinois Inc. Topical compositions for improved delivery of active agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU469815B2 (en) * 1971-04-14 1973-10-18 Anti-inflammatory compositions
SE375007B (de) * 1972-11-30 1975-04-07 Pharmacia Ab
FI854634A0 (fi) * 1985-11-22 1985-11-22 Labsystems Oy Foerfarande foer bestaemning av proteolytisk aktivitet.

Also Published As

Publication number Publication date
EP0420600A2 (de) 1991-04-03
DE69030476D1 (de) 1997-05-22
AU6317090A (en) 1991-04-11
EP0420600B1 (de) 1997-04-16
EP0420600A3 (en) 1992-11-19
CS275231B2 (en) 1992-02-19
CA2026166A1 (en) 1991-03-30
DE69030476T2 (de) 1997-11-27
US5244673A (en) 1993-09-14

Similar Documents

Publication Publication Date Title
ATE151640T1 (de) Verwendung von protease-inhibitoren als antiexudative, antiphlogistische und antimikrobielle mittel
AU5094985A (en) Wound healing agents
ES2098739T3 (es) Composiciones oftalmicas conteniendo una cyclosporin.
GR3024836T3 (en) Fatty acid based compositions for the control of established plant infections
GR3034921T3 (en) Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer.
ATE188119T1 (de) Heilmittel für wunden und hämorrhoiden
SE8903583D0 (sv) Cyclosporin ophthalmic compositions
FI970747A0 (fi) Yhdistelmävalmiste käytettäväksi immunologisissa sairauksissa
CA2190505A1 (en) Use of gel formulations as dressing agents
CA2309172A1 (en) Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions
FI955403A0 (fi) Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä
ATE295165T1 (de) Mittel zur adjuvanten therapie von demenzen enthaltend alpha-liponsäure
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
CA2340734A1 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
AU1944997A (en) Angiogenic inhibitor containing tissue factor pathway inhibitor
DE69024060D1 (de) Osteogenesis-stimulierende mittel.
AU589283B2 (en) Synergistic blood clot treatment composition comprising tissue plasminogen activator and a prostaglandin
AU3016089A (en) Inhibitors of lysyloxidase
BR9306800A (pt) Composição tópica oftalmológica e processo para a preparação de uma composição oftalmológica para uso tópico
FI913909A0 (fi) t-PA pro:n stabilointi
ATE80768T1 (de) Antimikrobielles mittel fuer saetze fuer in-vitrodiagnose.
AU2234897A (en) Ophthalmologically useful composition, products containing the composition and process for disinfecting and/or cleaning contact lenses
MX9705592A (es) Composiciones farmaceuticas que contienen corticosteroides y preparacion de las mismas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties